# Safety and Immunogenicity of Live Attenuated Influenza H5N2

> **NCT01841918** · PHASE2 · COMPLETED · sponsor: **Mahidol University** · enrollment: 150 (actual)

## Conditions studied

- Influenza Due to Influenza A Virus Subtype H5N2

## Interventions

- **BIOLOGICAL:** Avian Flu Vaccine

## Key facts

- **NCT ID:** NCT01841918
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841918, "Safety and Immunogenicity of Live Attenuated Influenza H5N2". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01841918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*